Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04655963 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotablePrimary endpoints: details revised at 1 of 3 entriesPrimary and study completion pushed from Jul 30, 2026 to Dec 30, 2026 · Eligibility criteria expanded, about 12 words · Publications: details revised at 1 of 1 entryShow 3 more changesShow less
Primary and study completion pushed from Jul 30, 2026 to Dec 30, 2026
Eligibility criteria expanded, about 12 words
Publications: details revised at 1 of 1 entry
MinorPrimary and study completion pushed from May 15, 2026 to Jul 30, 2026v18
MinorPrimary completion pushed from Mar 15, 2026 to May 15, 2026v17
MinorPrimary completion date: Dec 15, 2025 to Mar 15, 2026Completion date: Dec 15, 2025 to May 15, 2026v16Show 1 more changeShow less
Completion date: Dec 15, 2025 to May 15, 2026
MinorPrimary and study completion dates: Oct 30, 2025 to Dec 15, 2025v15
Show 13 earlier versionsHide 13 earlier versions
MinorPrimary and study completion dates: May 30, 2025 to Oct 30, 2025v14
MinorPrimary and study completion dates: Dec 30, 2024 to May 30, 2025v13
NotablePrimary and study completion dates: Dec 30, 2023 to Dec 30, 2024v12
NotablePrimary completion date: Jun 30, 2023 to Dec 30, 2023Trial status: Recruiting to Active, Not Recruiting · Enrollment target: estimated 40 to confirmed 20 · Completion date: Sep 1, 2023 to Dec 30, 2023 · 1 morev11Show 4 more changesShow less
Trial status: Recruiting to Active, Not Recruiting
Enrollment target: estimated 40 to confirmed 20
Completion date: Sep 1, 2023 to Dec 30, 2023
Site details revised
NotablePrimary completion date: Jun 30, 2022 to Jun 30, 2023Completion date: Sep 1, 2022 to Sep 1, 2023v10Show 1 more changeShow less
Completion date: Sep 1, 2022 to Sep 1, 2023
MinorPrimary completion date: Feb 2022 to Jun 30, 2022Completion date: Apr 1, 2022 to Sep 1, 2022v9Show 1 more changeShow less
Completion date: Apr 1, 2022 to Sep 1, 2022
MinorPrimary completion date: Oct 2021 to Feb 2022Completion date: Mar 1, 2022 to Apr 1, 2022v8Show 1 more changeShow less
Completion date: Mar 1, 2022 to Apr 1, 2022
MinorCompletion date: Oct 2021 to Mar 1, 2022v7
MinorPrimary and study completion dates: Jun 20, 2021 to Oct 2021v6
MinorPrimary and study completion dates: Mar 31, 2021 to Jun 20, 2021v5
MinorPrimary and study completion dates: Jul 31, 2021 to Mar 31, 2021Start date changed from estimate of Jan 2021 to Jan 14, 2021v4Show 1 more changeShow less
Start date changed from estimate of Jan 2021 to Jan 14, 2021
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Few treatments are available for post-stroke rehabilitation. The current study aims to develop a novel, short-term, high-dose repetitive transcranial magnetic stimulation (rTMS) based intervention to improve post-stroke cognitive problems. This study will test the safety as well as changes in cognitive function and brain activation with the administration of an accelerated rTMS protocol in chronic stroke.
Trial Details
NCT Number
NCT04655963
Lead Sponsor
Medical University of South Carolina Collaborators: National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)